Search

Displaying 511 - 520 of 530

The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment

Chait, A. and Eckel, R. The Chylomicronemia Syndrome Is Most Often Multifactorial. Ann Intern Med. 2019;170:626-634. doi:10.7326/M19-0203 more

Triglyceride and Triglyceride/ HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease

Prasad, M. et al. Triglyceride and Triglyceride/HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease. J Am Heart Assoc. 2019;8:e009442. DOI: 10.1161/JAHA.118.009442.) more

Access instructions for Endocrine Practice

2019/2020 FACE Application Period is Closed

Distinguish yourself as a leader in the endocrine field by becoming a Fellow of the American College of Endocrinology (FACE). The FACE Application is open to all AACE members in good standing. Eligible candidates must meet criteria set forth by the FACE Application Committee. FACE Applications for 2020 will only be accepted through an online process. You will need to be logged in to your AACE user account in order to complete the application process. Only AACE… more

FDA OKs First-Ever Nasal Glucagon for Severe Hypos in Diabetes

Medscape reports the US Food and Drug Administration (FDA) has approved the first nasally administered glucagon product (Baqsimi, Eli Lilly and Co) for the treatment of severe hypoglycemia for patients aged 4 years or older who have diabetes. The nasal powder is the first licensed glucagon product that is not delivered by injection and that does not require a multistep mixing process. more

A Message to AACE Members Regarding CMS Proposed Rules

Medicare imposed substantial cuts in reimbursements for the new and revised fine needle aspiration codes for 2019. AACE, together with the Endocrine Society and American Thyroid Association, advocated for you with letters to Centers for Medicare and Medicaid Services (CMS) and Congress opposing these cuts. We secured a win with the release of the proposed physician pay rule issued July 29. CMS has listed the FNA codes under the “potentially mis-valued” list, giving an opportunity for codes to be reviewed. AACE plans to write in support of the mis-valued list as a first step to… more

CDC Prediabetes Test Goal to Increase Public Awareness

The CDC recently launched in collaboration with Google Health, a prediabetes quiz that will pop up when end users search for certain medical information using their Google browser to bring more public awareness about prediabetes. Visit the Diabetes Resource Center for more details more

AACE Members Aided in Government's New Obesity Study

The Government Accountability Office (GAO) has released a new study on prescription drug use to treat obesity. Several physician members of American Association of Clinical Endocrinologists (AACE) — including Dr. W. Timothy Garvey, Dr. Ken Fuijoka, and Dr. Ania Jastreboff — participated in the study’s development and report. As many specialists in obesity medicine have experienced, few people with obesity use prescription drugs… more

AACE Conflicts of Interests Policy

The American Association of Clinical Endocrinologists, Inc. and the American College of Endocrinology, Inc. d/b/a American Association of Clinical Endocrinology (collectively “AACE”) is dedicated to elevating the practice of clinical endocrinology to improve global health. AACE is a recognized leader in the delivery of education, clinical practice guidelines, and other resources worldwide. Confidence and trust in the integrity of AACE’s resources are enhanced by maintaining independence and transparency in all relationships with related organizations and other entities. That integrity… more